Skip to main content
. Author manuscript; available in PMC: 2012 May 10.
Published in final edited form as: Genet Epidemiol. 2010 Sep;34(6):582–590. doi: 10.1002/gepi.20515

Table 3.

Top 10 Results for identified CNV regions, sorted by Liptak p-value, for the CAMP BMI analysis

SNP Chr. Position* FBAT Rank-based Liptak Liptak
(bp) p-value Wald p-value test p-value
rs1758827 10 56295820 4.931E-03 7.128E-05 4.68 2.902E-06
rs1831078 9 25416556 2.411E-03 2.138E-04 4.64 3.547E-06
rs1886314 13 67392298 3.583E-04 1.019E-02 4.16 3.133E-05
rs9351261 6 65171419 1.999E-02 4.989E-04 3.97 7.118E-05
rs11758713 6 67036364 2.593E-04 3.899E-02 3.83 1.285E-04
rs7072438 10 59013036 2.775E-02 7.840E-04 3.79 1.495E-04
rs696279 7 16700798 3.811E-03 1.133E-02 3.66 2.547E-04
rs11004706 10 56813669 7.685E-02 3.564E-04 3.64 2.681E-04
rs7856324 9 28366643 1.814E-03 2.145E-02 3.64 2.756E-04
*

SNP positions are from NCBI build 37.1. The FBAT p-value is the asymptotic p-value obtained from the Ionita-Laza FBAT – CNV test statistic. The Observed Wald p-value is the asymptotic p-value from a Wald test regressing the BMI phenotype on the expected parental CNV intensities. The Rank-based Wald p-value reflects the p-value based on the rank of the Wald test. The Liptak test is the value of the test statistic given in equation 2.2, which combines the FBAT p-value and the Rank-based Wald p-value. The Liptak p-value is the asymptotic p-value from this combined test statistic. Results with a Liptak p-value< 7.18×10−6 are significant at the α=0.05 level after Bonferroni correction for multiple comparisons.